Exane Derivatives’s Blackrock BLK Stock Holding History
Bought
Maintained
Sold
Other funds holding BLK
Exane Derivatives's BLK Position: Q2 2022 in Review
Exane Derivatives reduced its Blackrock (BLK) stake by 76% in Q2 2022, selling an estimated $92.5K and leaving 46 shares worth $28K. The position accounts for 0.02% of the portfolio, ranked #349.
Exane Derivatives first reported a position in BLK in Q4 2014 and has held it in 20 quarters since. The position peaked at $1.12M in Q1 2018. 1,751 funds tracked by Wall St. Rank hold BLK as of Q2 2022.
- Exane Derivatives held 46 shares of Blackrock worth $28K as of Q2 2022.
- Exane Derivatives sold 142 Blackrock shares in Q2 2022, an estimated $92.5K.
- Blackrock made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #349 holding.
- Exane Derivatives first reported a position in Blackrock in Q4 2014 and has held it in 20 quarters since.
- Exane Derivatives's Blackrock position peaked at $1.12M in Q1 2018.
- 1,751 funds tracked by Wall St. Rank held Blackrock as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.